PureTech Health plc Announces Tender Offer Results
Ticker: PTCHF · Form: 6-K · Filed: Jun 24, 2024 · CIK: 1782999
| Field | Detail |
|---|---|
| Company | Puretech Health PLC (PTCHF) |
| Form Type | 6-K |
| Filed Date | Jun 24, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: tender-offer, press-release
Related Tickers: PRTC
TL;DR
PureTech Health tender offer successful, more details on co-development coming.
AI Summary
On June 24, 2024, PureTech Health plc announced the results of its tender offer, which was successful. The company also issued a press release regarding its co-development activities, though specific details on the co-development are not provided in this filing excerpt.
Why It Matters
The successful tender offer indicates shareholder confidence or a strategic move by the company, potentially impacting its capital structure and future operations.
Risk Assessment
Risk Level: low — This filing is an informational update regarding a tender offer and press releases, with no immediate financial or operational risks disclosed.
Key Players & Entities
- PureTech Health plc (company) — Registrant
- June 24, 2024 (date) — Date of press releases
FAQ
What were the specific results of the tender offer?
The filing states the tender offer was successful, but does not provide specific numbers or percentages in this excerpt.
What is the subject of the second press release?
The second press release is titled 'Co-development' and was issued on June 24, 2024.
What is PureTech Health plc's stock exchange listing?
PureTech Health plc is listed on LSE: PRTC and Nasdaq: PRTC.
What is the company's principal executive office address?
The company's principal executive office is located at 6 Tide Street, Suite 400, Boston, Massachusetts 02210.
Does PureTech Health plc file annual reports under Form 20-F or 40-F?
PureTech Health plc indicates it files annual reports under Form 20-F.
Filing Stats: 266 words · 1 min read · ~1 pages · Grade level 13.6 · Accepted 2024-06-24 16:35:26
Filing Documents
- d813860d6k.htm (6-K) — 10KB
- d813860dex991.htm (EX-99.1) — 22KB
- d813860dex992.htm (EX-99.2) — 17KB
- 0001193125-24-166986.txt ( ) — 50KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PURETECH HEALTH PLC Date: June 24, 2024 By: /s/ Bharatt Chowrira Name: Bharatt Chowrira Title: Chief Executive Officer